N21: Patient education is (sometimes) better than cure.ECCO’23 CopenhagenYear: 2023
Authors: Müskens, B.(1)*;
(1)Amsterdam UMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands;P. (Petra) Waayenberg MSc K.H.N. (Nanne) De Boer MD PhDA S. (Sigrid) Müller-Schotte OD PhD FAAOB
N23: Burnout among European IBD specialists – a survey supported by ECCOECCO’23 CopenhagenYear: 2023
Authors: Sánta, A.(1)*;Volosin, M.(2);Farkas, K.(1);Keresztes, C.(3);Rafael , B.(4);Molnár, T.(1);
(1)Albert Szent-Györgyi Medical School- University of Szeged, Department of Medicine, Szeged, Hungary;(2)University of Szeged, Institute of Psychology, Szeged, Hungary;(3)Albert Szent-Györgyi Medical School- University of Szeged, Department for Medical Communication and Translation Studies, Szeged, Hungary;(4)Albert Szent-Györgyi Medical School- University of Szeged, Department of Preventive Medicine, Szeged, Hungary;
N24: At Home Calprotectin a United Kingdom Patient Perspectives and Tertiary Center ExperienceECCO’23 CopenhagenYear: 2023
Authors: Avery, P.(1)*;Adio, J.(1);Cornford, R.(2);Younge, L.(1);
(1)St Marks Hospital and Academic Institute, Inflammatory Bowel Disease, London, United Kingdom;(2)Northwick Park Hospital, Clinical Biochemistry, London, United Kingdom;
N25: Diagnostic delay and economic burden in ibd: a multicenter italian experience in patients treated with biologicsECCO’23 CopenhagenYear: 2023
Authors: Mocci, G.(1);Onidi, F.M.(1)*;Magri', S.(2);Bodini, G.(3);Lorenzetti, R.(4);Binaghi, L.(1);Dore, M.F.(1);Martello , S.(1);Usai Satta, P.(1);Elisei, W.(5);Tursi, A.(6);
(1)Arnas- Brotzu Hospital- Gastroenterology Unit, Department of Internal Medicine, Cagliari, Italy;(2)Emergency Hospital company - Gastroenterology Unit, Department of Internal Medicine, Catania, Italy;(3)Policlinico S. Martino- Gastroenterology Unit, Department of Internal Medicine, Genova, Italy;(4)Nuovo Regina Margherita - Gastroenterology Unit, Department of Internal Medicine, Roma, Italy;(5)S.Camillo Fonanini Hospital, Division of Gastroenterology, Roma, Italy;(6)Gastroenterologoly Unit- territorial, Department of Internal Medicine, Andria, Italy;
N26: Help-seeking experiences of patients with Inflammatory Bowel Disease from healthcare professionals: A qualitative descriptive studyECCO’23 CopenhagenYear: 2023
Authors: Byron, C.(1,2)*;Lehane, E.(2);Burton, A.(2);Cornally , N.(2);
(1)Cork University Hospital, Gastroenterology, Cork, Ireland;(2)University College Cork, School of Nursing and Midwifery, Cork, Ireland;
N27: Living well with IBD; An online survey from the UKECCO’23 CopenhagenYear: 2023
Authors: RadfordBSc- MSc- PGCert- PhD student, S.(1)*;Sawyer, R.(2);
(1)Nottingham University Hospitals NHS Trust, NIHR Nottingham Biomedical Research Centre- Gastrointestinal and Liver disorders, Nottingham, United Kingdom;(2)The Bottom Line IBD, The Bottom Line IBD, London, United Kingdom;
N28: Satisfaction with telemedicine programs in inflammatory bowel disease: a natiowise multicenter studyECCO’23 CopenhagenYear: 2023
Authors: Cano Sanz, N.(1)*;Serrano Redondo, M.(2);Jurado Monroy, R.M.(3);Suárez Álvarez, P.(1);García Prada, M.(1);Latras Cortés, I.(1);Sierra Ausín, M.(1);
(1)University Hospital of León, Department of Gastroenterology - IBD Unit, León, Spain;(2)University Hospital Marques de Valdecilla, Department of Gastroenterology - IBD Unit, Santander, Spain;(3)Puertollano Hospital, Department of Gastroenterology - IBD Unit, Puertollano, Spain;
N31: Nothing about us, without us: Developing a reliable IBD information source on sexual well-being by patients and for patientsECCO’23 CopenhagenYear: 2023
Authors: Fourie, S.(1);Johnstone, L.(1)*;Czuber-Dochan, W.(2);
(1)University of Oxford, Radcliffe Department of Medicine, Oxford, United Kingdom;(2)King's College of London, Florence Nightingale Faculty of Nursing- Midwifery and palliative Care, London, United Kingdom;
OP01: Sequencing-based gene network analysis reveals a profound role for ferroptosis key gene GPX4 in post-operative endoscopic recurrence in Crohn's diseaseECCO’23 CopenhagenYear: 2023
Authors: Verstockt, S.(1)*;Machiels, K.(1);Dehairs, J.(2);Rems, K.(1);De Greef, I.(1);Jans, D.(3);Sabino, J.(1,4);Ferrante, M.(1,4);Vermeire, S.(1,4);Verstockt, B.(1,4);
(1)KU Leuven, Department of Chronic Diseases- Metabolism and Ageing CHROMETA, Leuven, Belgium;(2)KU Leuven, Department of Oncology, Leuven, Belgium;(3)KU Leuven, Department of Human Genetics, Leuven, Belgium;(4)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;
OP02: Distinct biological profiles associated with the risk of short-term relapse and mid/long-term relapse in Crohn's disease patients stopping infliximabECCO’23 CopenhagenYear: 2023
Authors: PierreDr., N.(1)*;Huynh-Thu, V.A.(2);Baiwir, D.(3);Mazzucchelli, G.(4);Fléron, M.(3);Trzpiot, L.(4);Eppe, G.(4);Laharie, D.(5);Satsangi, J.(6);Colombel, J.F.(7);Hertervig, E.(8);Meuwis, M.A.(1);Louis, E.(9);
(1)University of Liege, Laboratory of Translational Gastroenterology, Liege, Belgium;(2)University of Liege, Department of Electrical Engineering and Computer Science, Liege, Belgium;(3)University of Liege, GIGA Proteomics Facility, Liege, Belgium;(4)University of Liege, Laboratory of Mass Spectrometry, Liege, Belgium;(5)Centre Hospitalier Universitaire de Bordeaux, Service d'Hépato-gastroentérologie et oncologie digestive, Bordeaux, France;(6)John Radcliffe Hospital, Translational Gastroenterology Unit, Oxford, United Kingdom;(7)Icahn School of Medicine at Mount Sina, Division of Gastroenterology, New York, United States;(8)Skane University Hospital, Department of Gastroenterology, Lund, Sweden;(9)Liege University Hospital, Hepato-Gastroenterology and Digestive Oncology Department, Liege, Belgium;GETAID and the SPARE-Biocycle research group
OP03: Highly stable epigenome-wide peripheral blood DNA methylation signatures accurately predict endoscopic response to adalimumab, vedolizumab and ustekinumab in Crohn's disease patients: The EPIC-CD studyECCO’23 CopenhagenYear: 2023
Authors: JoustraMD., V.(1)*;Li Yim, A.(2,3);Hageman, I.(2);Levin, E.(4);Noble, A.(5);Chapman, T.(6);McGregor, C.(6);Adams, A.(6);Satsangi, J.(6);de Jonge, W.(2);Henneman, P.(3);D'Haens, G.(1);
(1)Amsterdam UMC location AMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Amsterdam UMC location AMC, Tytgat institute for Liver and Intestinal Research, Amsterdam, The Netherlands;(3)Amsterdam UMC location AMC, Genome Diagnostics Laboratory- Department of Clinical Genetics, Amsterdam, The Netherlands;(4)Horaizon, bv, Delft, The Netherlands;(5)Oxford University - Hospitals NHS Foundation Trust - John Radcliffe Hospital, Translational Gastroenterology Unit - NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom;(6)Oxford University- Hospitals NHS Foundation Trust- John Radcliffe Hospital, Translational Gastroenterology Unit- NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom;on behalf of the EPIC-CD Consortium
OP04: Efficacy of upadacitinib in ulcerative colitis: A phase 3 post hoc analysis of biologic- and anti-TNF-inadequate response patientsECCO’23 CopenhagenYear: 2023
Authors: Vermeire, S.(1)*;Danese, S.(2);Hébuterne, X.(3);D'Haens, G.(4);Takeuchi, K.(5);Finney-Hayward, T.(6);Klaff, J.(6);Holweg, C.T.J.(6);Rubin, D.T.(7);
(1)University Hospital Leuven, Department of Gastroenterology & Hepatology, Leuven, Belgium;(2)Humanitas Clinical and Research Center - IRCCS - and Humanitas University, Department of Biomedical Sciences, Milan, Italy;(3)University Côte d'Azur, Gastroentérology and Clinical Nutrition, Nice, France;(4)Amsterdam University Medical Centers, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(5)Tsujinaka Hospital Kashiwanoha, IBD Center- Department of Gastroenterology and Hepatology, Chiba, Japan;(6)AbbVie Inc, Immunology, North Chicago, United States;(7)University of Chicago Medicine, Section of Gastroenterology- Hepatology and Nutrition, Chicago, United States;
OP05: High-dimensional single-cell analysis identifies cellular signatures associated with response to vedolizumab therapy in ulcerative colitisECCO’23 CopenhagenYear: 2023
Authors: Pibiri, P.(1)*;Sun, S.(1);Karmi, N.(1);Oelen, R.(2);de Jong, S.(1);Bangma, A.(1);Hermoso, M.(1);Paraskevopoulou, M.(3);Farahmand, S.(3);Weersma, R.(1);Bigaeva, E.(1);Festen, E.(1);Xia, G.(3);Teunis, J.(4);Bleck, B.(3);
(1)University Medical Center Groningen, Hepatology and Gastroenterology, Groningen, The Netherlands;(2)University Medical Center Groningen, Genetics, Groningen, The Netherlands;(3)Takeda Pharmaceuticals, GI Drug Discovery Unit, Cambridge MA, United States;(4)University Medical Center Groningen, Flow Cytometry Unit, Groningen, The Netherlands;
OP06: Multiomic interrogation of the epithelium in active Ulcerative Colitis reveals dysregulated myeloid cells associated with non-response to anti-Tumour Necrosis Factor therapy.ECCO’23 CopenhagenYear: 2023
Authors: Jha , D.(1)*;Al-Taie , Z.(2);Krek , A.(3);Eshghi , S.(4);Tankelevich , M.(1);Meringer , H.(5);Cossarini , F.(6);Canales-Herrerias , P.(1);Livanos , A.E.(1); Polydorides , A.D.(7);Martin , J.(8);Ko , H.M.(9);McBride , J.(4);Hackney , J.(10);Colombel , J.F.(1);Argmann , C.(11);Suarez-Farinas , M.(11);Petralia , F.(11);Mehandru , S.(1);
(1)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York City, United States;(2)Icahn School of Medicine at Mount Sinai, Genetics and Genomic Sciences- Population Health Science and Policy, New York City, United States;(3)Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences-, New York City, United States;(4)Genentech Inc, OMNI Biomarker Development, San Francisco, United States;(5)Assuta Ashdod Medical Center, Department of Gastroenterology and Liver diseases, Ashdod, Israel;(6)Icahn School of Medicine at Mount Sinai, Infectious Diseases, New York City, United States;(7)Icahn School of Medicine at Mount Sinai, Pathology, New York City, United States;(8)Université de Nantes, Centre de Recherche en Transplantation et Immunologie, Nantes, France;(9)Columbia University, Pathology, New York City, United States;(10)Genentech Inc, OMNI Bioinformatics, San Francisco, United States;(11)Icahn School of Medicine at Mount Sinai, Genetics and Genomic Sciences, New York City, United States;
OP07: Absolute and relative risks of kidney and urological complications in patients with Inflammatory Bowel DiseaseECCO’23 CopenhagenYear: 2023
Authors: Yang, Y.(1)*;Ludviggson, J.F.(1,2);Olén, O.(3,4,5);Sjölander, A.(1);Carrero, J.J.(1,6);
(1)Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden;(2)Örebro University Hospital, Department of Paediatrics, Örebro, Sweden;(3)Karolinska Institutet, Clinical Epidemiology Division- Department of Medicine Solna, Stockholm, Sweden;(4)Stockholm South General Hospital, Sachs' Children and Youth Hospital, Stockholm, Sweden;(5)Karolinska Institutet, Department of Clinical Science and Education- Södersjukhuset, Stockholm, Sweden;(6)Karolinska Institutet, Division of Nephrology- Department of Clinical Sciences- Danderyd Hospital, Stockholm, Sweden;
OP08: Mucosal healing with vedolizumab in inflammatory bowel disease patients with chronic pouchitis: Evidence from EARNEST, a randomized, double-blind, placebo-controlled trialECCO’23 CopenhagenYear: 2023
Authors: Jairath, V.(1,2)*;Feagan, B.G.(2);Silverberg, M.S.(3);Danese, S.(4);Gionchetti, P.(5);Löwenberg, M.(6);Bressler, B.(7);Ferrante, M.(8);Hart, A.(9);Lindner, D.(10);Escher, A.(10);Jones, S.(10);Shen, B.(11);Travis, S.(12);
(1)Department of Medicine- Division of Gastroenterology, Western University, London- ON, Canada;(2)Alimentiv, Alimentiv, London- ON, Canada;(3)Mount Sinai Hospital, Division of Gastroenterology- Department of Medicine- Mount Sinai Hospital Inflammatory Bowel Disease Centre, Toronto- ON, Canada;(4)IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Gastroenterology and Endoscopy, Milan, Italy;(5)University of Bologna, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Bologna, Italy;(6)Amsterdam University Medical Centre, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(7)University of British Columbia, Department of Medicine- Division of Gastroenterology, Vancouver- BC, Canada;(8)University Hospitals Leuven- KU Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(9)St Mark's Hospital and Imperial College London, IBD Unit, London, United Kingdom;(10)Takeda, Takeda, Zurich, Switzerland;(11)Columbia University Irving Medical Center, Gastroenterology, New York- NY, United States;(12)John Radcliffe Hospital, Translational Gastroenterology Unit, Oxford, United Kingdom;
OP09: Long-term Colectomy rates of Ulcerative Colitis over 40-year of Different Therapeutic eras – Results from a Western Hungarian Population-based Inception Cohort between 1977–2020ECCO’23 CopenhagenYear: 2023
Authors: LakatosPhD, P.L.(1)*;Gonczi, L.(2);Lakatos, L.(3);Golovics, P.A.(4);Pandur, T.(5);David, G.(3);Erdelyi, Z.(3);Szita , I.(3);
(1)Mcgill University Health Center, IBD Centre, Montréal, Canada;(2)Semmelweis University, Department of Medicine and Oncology, Budapest, Hungary;(3)Ferenc Csolnoky Hospital, Department of Gastroenterology, Veszprem, Hungary;(4)Hungarian Defence Forces Medical Centre, Department of Gastroenterology, Budapest, Hungary;(5)Grof Esterhazy Hospital, Department of Gastroenterology, Papa, Hungary;
